| | | Single nucleotide variant (synonymous variant) | Prostate cancer, hereditary, 2 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Prostate cancer, hereditary, 2 +2 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +3 more | |
| | | Single nucleotide variant (synonymous variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (intron variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (intron variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (intron variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (intron variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (intron variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | Prostate cancer, hereditary, 2 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 +2 more | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 +2 more | |